Cargando…

Neuroblastoma

Introduction of new technologies and their applications to neuroblastoma diagnosis, treatment, and therapy assessment are explained. Role of molecular ghenetics in diagnosis and therapy for neuroblastoma patients is detailed. Molecular detection of minimal residual neuroblastoma is described. Magnet...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Hayat, M.A (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Dordrecht : Springer Netherlands : Imprint: Springer, 2012.
Edición:1st ed. 2012.
Colección:Pediatric Cancer, Diagnosis, Therapy, and Prognosis, 1
Temas:
Acceso en línea:Texto Completo

MARC

LEADER 00000nam a22000005i 4500
001 978-94-007-2418-1
003 DE-He213
005 20220119053443.0
007 cr nn 008mamaa
008 111101s2012 ne | s |||| 0|eng d
020 |a 9789400724181  |9 978-94-007-2418-1 
024 7 |a 10.1007/978-94-007-2418-1  |2 doi 
050 4 |a RC261-271 
072 7 |a MJCL  |2 bicssc 
072 7 |a MED062000  |2 bisacsh 
072 7 |a MJCL  |2 thema 
082 0 4 |a 571.978  |2 23 
082 0 4 |a 616.994  |2 23 
245 1 0 |a Neuroblastoma  |h [electronic resource] /  |c edited by M.A. Hayat. 
250 |a 1st ed. 2012. 
264 1 |a Dordrecht :  |b Springer Netherlands :  |b Imprint: Springer,  |c 2012. 
300 |a XVIII, 262 p. 40 illus., 24 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Pediatric Cancer, Diagnosis, Therapy, and Prognosis,  |x 2211-8004 ;  |v 1 
520 |a Introduction of new technologies and their applications to neuroblastoma diagnosis, treatment, and therapy assessment are explained. Role of molecular ghenetics in diagnosis and therapy for neuroblastoma patients is detailed. Molecular detection of minimal residual neuroblastoma is described. Magnetic resonance imaging and  spectroscopy are detailed for diagnosing this solid, extracranial cancer. Targets for therapeutic intervention in neuroblastoma are identified, including targeting multidrug resistance in this cancer. Ornithine decarboxylase and polyamines are novel targets for therapeutic intervention. The effectiveness of chemotherapy with oral irinotecan and temozolomide is explained. The role of transcription factors (GATA) in neuroblastoma pregression is  also included. 
650 0 |a Cancer. 
650 0 |a Pediatrics. 
650 0 |a Radiology. 
650 0 |a Children-Surgery. 
650 1 4 |a Cancer Biology. 
650 2 4 |a Pediatrics. 
650 2 4 |a Radiology. 
650 2 4 |a Pediatric Surgery. 
700 1 |a Hayat, M.A.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9789400724198 
776 0 8 |i Printed edition:  |z 9789400724174 
776 0 8 |i Printed edition:  |z 9789401779098 
830 0 |a Pediatric Cancer, Diagnosis, Therapy, and Prognosis,  |x 2211-8004 ;  |v 1 
856 4 0 |u https://doi.uam.elogim.com/10.1007/978-94-007-2418-1  |z Texto Completo 
912 |a ZDB-2-SBL 
912 |a ZDB-2-SXB 
950 |a Biomedical and Life Sciences (SpringerNature-11642) 
950 |a Biomedical and Life Sciences (R0) (SpringerNature-43708)